Funding and access to high cost medicines in public hospitals in Australia: Decision-makers' perspectives
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Victor R. Fuchs, 2018.
"Economics, Values, and Health Care Reform,"
World Scientific Book Chapters, in: Health Economics and Policy Selected Writings by Victor Fuchs, chapter 39, pages 497-531,
World Scientific Publishing Co. Pte. Ltd..
- Fuchs, Victor R, 1996. "Economics, Values, and Health Care Reform," American Economic Review, American Economic Association, vol. 86(1), pages 1-24, March.
- Productivity Commission, 2005. "Impacts of Advances in Medical Technology in Australia," Research Reports, Productivity Commission, Government of Australia, number 17.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Grover, Piyush & Babar, Zaheer-Ud-Din & Oehmen, Raoul & Vitry, Agnes, 2018. "Medicines access programs to cancer medicines in Australia and New Zealand: An exploratory study," Health Policy, Elsevier, vol. 122(3), pages 243-249.
- Whitty, Jennifer A. & Littlejohns, Peter, 2015. "Social values and health priority setting in Australia: An analysis applied to the context of health technology assessment," Health Policy, Elsevier, vol. 119(2), pages 127-136.
- Prilepskiy, Ilya (Прилепский, Илья), 2017. "Factors of Exports Dynamics and Import Substitution after the Sharp Exchange Rate Depreciation [Факторы Динамики Экспорта И Импортозамещения После Резкого Ослабления Курса Национальной Валюты]," Ekonomicheskaya Politika / Economic Policy, Russian Presidential Academy of National Economy and Public Administration, vol. 3, pages 100-133, June.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Frank R. Lichtenberg, 2014.
"Has Medical Innovation Reduced Cancer Mortality?,"
CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
- Frank R. Lichtenberg, 2010. "Has medical innovation reduced cancer mortality?," NBER Working Papers 15880, National Bureau of Economic Research, Inc.
- Kurt Hornschild & Stephan Raab & Jörg-Peter Weiß, 2005. "Die Medizintechnik am Standort Deutschland: Chancen und Risiken durch technologische Innovationen, Auswirkungen auf und durch das nationale Gesundheitssystem sowie potentielle Wachstumsmärkte im Ausla," DIW Berlin: Politikberatung kompakt, DIW Berlin, German Institute for Economic Research, edition 2, volume 10, number pbk10.
- Daron Acemoglu & Amy Finkelstein, 2008.
"Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector,"
Journal of Political Economy, University of Chicago Press, vol. 116(5), pages 837-880, October.
- Daron Acemoglu & Amy Finkelstein, 2006. "Input and Technology Choices in Regulated Industries: Evidence From the Health Care Sector," NBER Working Papers 12254, National Bureau of Economic Research, Inc.
- Colombier, Carsten & Weber, Werner, 2009.
"Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis,"
MPRA Paper
26747, University Library of Munich, Germany, revised Nov 2009.
- Colombier, Carsten & Weber, Werner, 2009. "Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis," MPRA Paper 26712, University Library of Munich, Germany, revised Jun 2010.
- Victor R. Fuchs, 2000.
"Medicare Reform: The Larger Picture,"
Journal of Economic Perspectives, American Economic Association, vol. 14(2), pages 57-70, Spring.
- Victor R. Fuchs, 2000. "Medicare Reform: The Larger Picture," NBER Working Papers 7504, National Bureau of Economic Research, Inc.
- Victor R. Fuchs & Alan B. Krueger & James M. Poterba, 1997. "Why do Economists Disagree About Policy?," NBER Working Papers 6151, National Bureau of Economic Research, Inc.
- Stern, David I., 1997. "Limits to substitution and irreversibility in production and consumption: A neoclassical interpretation of ecological economics," Ecological Economics, Elsevier, vol. 21(3), pages 197-215, June.
- Bonny Parkinson, 2013. "Pharmaceutical policy in Australia. CHERE Working Paper 2013/01," Working Papers 2013/01, CHERE, University of Technology, Sydney.
- Djellal, Faridah & Gallouj, FaIz, 2005.
"Mapping innovation dynamics in hospitals,"
Research Policy, Elsevier, vol. 34(6), pages 817-835, August.
- Faridah Djellal & Faïz Gallouj, 2005. "Mapping innovation dynamics in hospitals," Post-Print halshs-01133749, HAL.
- Paul Windrum, 2013. "The co-production of health innovations," Chapters, in: Faïz Gallouj & Luis Rubalcaba & Paul Windrum (ed.), Public–Private Innovation Networks in Services, chapter 9, pages 228-246, Edward Elgar Publishing.
- Harold Luft, 2006. "What Works and What Doesn’t Work Well in the US Healthcare System," PharmacoEconomics, Springer, vol. 24(2), pages 15-28, December.
- Nolan Miller & Karen Eggleston & Richard Zeckhauser, 2006.
"Provider choice of quality and surplus,"
International Journal of Health Economics and Management, Springer, vol. 6(2), pages 103-117, June.
- Karen Eggleston & Nolan Miller & Richard Zeckhauser, 2003. "Provider Choice of Quality and Surplus," Discussion Papers Series, Department of Economics, Tufts University 0308, Department of Economics, Tufts University.
- Borger, Christine & Rutherford, Thomas F. & Won, Gregory Y., 2008. "Projecting long term medical spending growth," Journal of Health Economics, Elsevier, vol. 27(1), pages 69-88, January.
- Laurence C. Baker, 2000. "Managed Care and Technology Adoption in Health Care: Evidence from Magnetic Resonance Imaging," NBER Working Papers 8020, National Bureau of Economic Research, Inc.
- Hyejin Lee & Dong-Yop Oh & Ming Meng, 2019. "Stationarity and cointegration of health care expenditure and GDP: evidence from tests with smooth structural shifts," Empirical Economics, Springer, vol. 57(2), pages 631-652, August.
- Karine Lamiraud & Stephane Lhuillery, 2016.
"Endogenous Technology Adoption and Medical Costs,"
Health Economics, John Wiley & Sons, Ltd., vol. 25(9), pages 1123-1147, September.
- Lamiraud, Karine & Lhuillery, Stephane, 2015. "Endogenous Technology Adoption and Medical Costs," ESSEC Working Papers WP1518, ESSEC Research Center, ESSEC Business School.
- Karine Lamiraud & Stéphane Lhuillery, 2016. "Endogenous Technology Adoption and Medical Costs," Post-Print hal-01512885, HAL.
- Klein, Daniel B. & Stern, Charlotta, 2005. "Narrow-Tent Democrats and Fringe Others: The Policy Views of Social Science Professors," Working Paper Series 8/2005, Stockholm University, Swedish Institute for Social Research.
- Victor R. Fuchs, 2005.
"Health, Government, and Irving Fisher,"
American Journal of Economics and Sociology, Wiley Blackwell, vol. 64(1), pages 407-425, January.
- Victor R. Fuchs, 1998. "Health, Government, and Irving Fisher," NBER Working Papers 6710, National Bureau of Economic Research, Inc.
- Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015.
"Public health insurance expansions and hospital technology adoption,"
Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2012. "Public Health Insurance Expansions and Hospital Technology Adoption," Working Papers 2012-08, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014. "Public Health Insurance Expansions and Hospital Technology Adoption," Working Papers 2014-04, Indiana University, Kelley School of Business, Department of Business Economics and Public Policy.
- Seth Freedman & Haizhen Lin & Kosali Simon, 2014. "Public Health Insurance Expansions and Hospital Technology Adoption," NBER Working Papers 20159, National Bureau of Economic Research, Inc.
- Lichtenberg, Frank R. & Tatar, Mehtap & Çalışkan, Zafer, 2014. "The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010," Health Policy, Elsevier, vol. 117(3), pages 361-373.
More about this item
Keywords
Priority setting Australia High cost medicines Public hospitals;Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:92:y:2009:i:1:p:27-34. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.